- Home
- BDRX vs AEMD Comparison
BDRX vs AEMD Comparison
Compare BDRX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- AEMD
- Stock Information
- Founded
- BDRX 2000
- AEMD 1984
- Country
- BDRX United Kingdom
- AEMD United States
- Employees
- BDRX N/A
- AEMD N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- AEMD Medical/Dental Instruments
- Sector
- BDRX Health Care
- AEMD Health Care
- Exchange
- BDRX Nasdaq
- AEMD Nasdaq
- Market Cap
- BDRX 3.2M
- AEMD 3.4M
- IPO Year
- BDRX N/A
- AEMD N/A
- Fundamental
- Price
- BDRX $5.20
- AEMD $5.10
- Analyst Decision
- BDRX
- AEMD Buy
- Analyst Count
- BDRX 0
- AEMD 2
- Target Price
- BDRX N/A
- AEMD $287.50
- AVG Volume (30 Days)
- BDRX 163.9K
- AEMD 50.4K
- Earning Date
- BDRX 09-12-2025
- AEMD 11-12-2025
- Dividend Yield
- BDRX N/A
- AEMD N/A
- EPS Growth
- BDRX N/A
- AEMD N/A
- EPS
- BDRX N/A
- AEMD N/A
- Revenue
- BDRX N/A
- AEMD N/A
- Revenue This Year
- BDRX N/A
- AEMD N/A
- Revenue Next Year
- BDRX N/A
- AEMD N/A
- P/E Ratio
- BDRX N/A
- AEMD N/A
- Revenue Growth
- BDRX N/A
- AEMD N/A
- 52 Week Low
- BDRX $4.88
- AEMD $4.02
- 52 Week High
- BDRX $92.00
- AEMD $84.40
- Technical
- Relative Strength Index (RSI)
- BDRX 42.34
- AEMD 64.85
- Support Level
- BDRX $4.88
- AEMD $4.13
- Resistance Level
- BDRX $5.65
- AEMD $4.60
- Average True Range (ATR)
- BDRX 0.64
- AEMD 0.39
- MACD
- BDRX -0.09
- AEMD -0.14
- Stochastic Oscillator
- BDRX 21.89
- AEMD 57.22
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.